Literature DB >> 3015128

Homologous up-regulation of the 1,25 (OH)2 vitamin D3 receptor in rats.

E M Costa, D Feldman.   

Abstract

This study investigates the ability of vitamin D-metabolites to regulate 1,25(OH)2D3 receptors in vivo. Rats made vitamin D-deficient were treated with 1,25(OH)2D3 or vehicle for 1-5 days. In treated animals, receptors for 1,25(OH)2D3 in kidney increased dramatically compared with control levels. An increase in specific binding to 220% of control was seen after 2 doses of hormone, which reached to 336% after 5 days of treatment. Intestinal receptors increased to only 130% of control levels after 5 days of treatment. In vitamin D-replete animals, the difference between control and treated groups was slightly greater when endogenously occupied sites were measured by exchange (TPCK). However, significant changes were observed only after 4 days of hormone treatment. The data indicate that homologous up-regulation of the 1,25(OH)2D3 receptor occurs in vivo. The difference in response in kidney and in intestine suggests differential importance of up-regulation in various organs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015128     DOI: 10.1016/0006-291x(86)91141-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  The mRNA expression of the human 1,25-dihydroxyvitamin D3 receptor and the c-myc protooncogene in cultured human keratinocytes.

Authors:  N M Hanafin; K S Persons; M F Holick
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

2.  Cloning and characterization of the mouse vitamin D receptor promoter.

Authors:  F Jehan; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  Parathyroid hormone decreases renal vitamin D receptor expression in vivo.

Authors:  Kevin D Healy; Janeen L Vanhooke; Jean M Prahl; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-15       Impact factor: 11.205

4.  Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D.

Authors:  Loan Nguyen-Yamamoto; Andrew C Karaplis; Rene St-Arnaud; David Goltzman
Journal:  J Am Soc Nephrol       Date:  2016-08-17       Impact factor: 10.121

5.  Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.

Authors:  Srilatha Swami; Aruna V Krishnan; Jennifer Y Wang; Kristin Jensen; Ronald Horst; Megan A Albertelli; David Feldman
Journal:  Endocrinology       Date:  2012-03-27       Impact factor: 4.736

6.  Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo.

Authors:  T Naveh-Many; R Marx; E Keshet; J W Pike; J Silver
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

7.  Serum calcium and vitamin D regulate 1,25-dihydroxyvitamin D3 receptor concentration in rat kidney in vivo.

Authors:  M E Sandgren; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Evidence for in vivo upregulation of 1,25(OH)2 vitamin D3 receptor in human monocytes.

Authors:  J Merke; M Nawrot; U Hügel; A Szabo; E Ritz
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

9.  Evidence for in vivo upregulation of the intestinal vitamin D receptor during dietary calcium restriction in the rat.

Authors:  M J Favus; D J Mangelsdorf; V Tembe; B J Coe; M R Haussler
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  Vitamin D receptors in breast cancer cells.

Authors:  R R Buras; L M Schumaker; F Davoodi; R V Brenner; M Shabahang; R J Nauta; S R Evans
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.